wasn't sure whether to bump this or the hillarious kill carmel CVT thread but this one seems most 'on topic'.

http://www.investor.comvita.com/ - annual report is out today.

makes for interesting reading. Doesn't seem like much new information - board as been stressing a create sh value mantra for a wee while now.

Can't aregue with their big sales growth though - or is this all by acquisition?

As a long term holder - bought pre-ipo and regret not selling at 270. I should have remembered the rules:

1. growth co's are often overvalued due to analyst optimisim
2. ipos usually underperform once ititial buying has subsided

anyone care to comment on the result and whether this co is a buy hold or sell and why

cheers